Patent details
EP1663989
Title:
CRYSTALLINE FORM OF BIS (E)-7- 4-(4-FLUOROPHENYL)-6-IS OPROPYL-2- METHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL&r sqb;(3R,5S)-3,5-DIHYDROXYHEPT-6 -ENOICACID CALCIUM SALT
Basic Information
- Publication number:
- EP1663989
- PCT Application Number:
- PCT/GB/2004/003829
- Type:
- European Patent Granted for LU
- Legal Status:
- Expired
- Application number:
- EP047683768
- PCT Publication Number:
- WO/2005/023779
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CRYSTALLINE FORM OF BIS (E)-7- 4-(4-FLUOROPHENYL)-6-IS OPROPYL-2- METHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL&r sqb;(3R,5S)-3,5-DIHYDROXYHEPT-6 -ENOICACID CALCIUM SALT
- French Title of Invention:
- FORME CRISTALLINE DU SEL DE CALCIUM DE BIS ACIDE (E)-7- 4-(4-FLUOROPHENYL)-6-ISOPROPYL-2- METHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL (3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIQUE
- German Title of Invention:
- KRISTALLINE FORM VON BISÖ(E)-7-Ö4-(4-FLUORPHENYL)-6-ISOPROPYL-2-ÖMETHYL(METHYLSULFONYL)AMINOÜPYRIMIDIN-5-YLÜ(3R,5S)-3,5-DIHYDROXYHEPT-6-ENSÄUREÜ-CALCIUMSALZ
- SPC Number:
-
Dates
- Filing date:
- 08/09/2004
- Grant date:
- 15/04/2009
- EP Publication Date:
- 15/04/2009
- PCT Publication Date:
- 17/03/2005
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/06/2006
- EP B1 Publication Date:
- 15/04/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 08/09/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/09/2004
-
-
- Name:
- AstraZeneca UK Limited
- Address:
- 15 Stanhope Gate, London, Greater London W1K 1LN, United Kingdom (GB)
Agent
- Name:
- VAN MALDEREN MICHEL
- From:
- 28/05/2009
- Address:
- ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- BOOTH Rebecca, Jane AstraZeneca Charter Way
- Address:
- United Kingdom (GB)
2
- Name:
- CRABB Jeffrey, Norman AstraZeneca Avlon Works
- Address:
- United Kingdom (GB)
3
- Name:
- JONES David, Wyn, Calvert AstraZeneca
- Address:
- United Kingdom (GB)
4
- Name:
- HORBURY John AstraZeneca Avlon Works
- Address:
- United Kingdom (GB)
5
- Name:
- CITTERN Peter, Anthony AstraZeneca Avlon Works
- Address:
- United Kingdom (GB)
Priority
1
- Priority Number:
- 0321127
- Priority Date:
- 10/09/2003
- Priority Country:
- United Kingdom (GB)
2
- Priority Number:
- 0404859
- Priority Date:
- 04/03/2004
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
-
C07D 239/42;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 25/08/2023
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 300 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
Filing date |
Document type |
Number of pages |